These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12922085)

  • 1. Antigen dependent adverse reactions and seroconversion of a tick-borne encephalitis vaccine in children.
    Eder G; Kollaritsch H
    Vaccine; 2003 Sep; 21(25-26):3575-83. PubMed ID: 12922085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized, phase II dose-finding studies of a modified tick-borne encephalitis vaccine: evaluation of safety and immunogenicity.
    Ehrlich HJ; Pavlova BG; Fritsch S; Poellabauer EM; Loew-Baselli A; Obermann-Slupetzky O; Maritsch F; Cil I; Dorner F; Barrett PN
    Vaccine; 2003 Dec; 22(2):217-23. PubMed ID: 14615149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination against tick-borne encephalitis (TBE): influence of simultaneous application of TBE immunoglobulin on seroconversion and rate of adverse events.
    von Hedenström M; Heberle U; Theobald K
    Vaccine; 1995; 13(8):759-62. PubMed ID: 7483792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination against tick-borne encephalitis--distant evaluation.
    Bobrowska E; Grzeszczuk A; Prokopowicz D
    Rocz Akad Med Bialymst; 1996; 41(1):44-50. PubMed ID: 8673804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety, immunogenicity and tolerability of a new pediatric tick-borne encephalitis (TBE) vaccine, free of protein-derived stabilizer.
    Zent O; Banzhoff A; Hilbert AK; Meriste S; Słuzewski W; Wittermann Ch
    Vaccine; 2003 Sep; 21(25-26):3584-92. PubMed ID: 12922086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody response following administration of two paediatric tick-borne encephalitis vaccines using two different vaccination schedules.
    Wittermann C; Schöndorf I; Gniel D
    Vaccine; 2009 Mar; 27(10):1661-6. PubMed ID: 18940221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity against Far Eastern and Siberian subtypes of tick-borne encephalitis (TBE) virus elicited by the currently available vaccines based on the European subtype: systematic review and meta-analysis.
    Domnich A; Panatto D; Arbuzova EK; Signori A; Avio U; Gasparini R; Amicizia D
    Hum Vaccin Immunother; 2014; 10(10):2819-33. PubMed ID: 25483679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative study of inactivated cultured vaccines against tick-borne encephalitis manufactured in Russia and in Austria by the "Immuno" firm].
    Vorob'eva MS; Rasshchepkina MN; Ladyzhenskaia IP; Gorbunov MA; Pavlova LI; Bektimirov TA
    Vopr Virusol; 1996; 41(5):221-4. PubMed ID: 8967069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized phase II study of a new tick-borne encephalitis vaccine using three different doses and two immunization regimens.
    Harabacz I; Bock H; Jüngst C; Klockmann U; Praus M; Weber R
    Vaccine; 1992; 10(3):145-50. PubMed ID: 1557929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term persistence of tick-borne encephalitis antibodies in children 5 years after first booster vaccination with Encepur Children.
    Wittermann C; Petri E; Zent O
    Vaccine; 2009 Mar; 27(10):1585-8. PubMed ID: 19162115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical evaluation to determine the appropriate paediatric formulation of a tick-borne encephalitis vaccine.
    Pöllabauer EM; Fritsch S; Pavlova BG; Löw-Baselli A; Firth C; Koska M; Maritsch F; Barrett PN; Ehrlich HJ
    Vaccine; 2010 Jun; 28(29):4558-65. PubMed ID: 20452432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five year follow-up after primary vaccination against tick-borne encephalitis in children.
    Wittermann C; Izu A; Petri E; Gniel D; Fragapane E
    Vaccine; 2015 Apr; 33(15):1824-9. PubMed ID: 25728316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Field effectiveness of vaccination against tick-borne encephalitis.
    Heinz FX; Holzmann H; Essl A; Kundi M
    Vaccine; 2007 Oct; 25(43):7559-67. PubMed ID: 17869389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term immunity after vaccination against tick-borne encephalitis with Encepur using the rapid vaccination schedule.
    Beran J; Douda P; Gniel D; Zent O
    Int J Med Microbiol; 2004 Apr; 293 Suppl 37():130-3. PubMed ID: 15146994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity and reactogenicity of a highly purified vaccine against tick-borne encephalitis.
    Kunz C; Heinz FX; Hofmann H
    J Med Virol; 1980; 6(2):103-9. PubMed ID: 7241091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A cultured concentrated inactivated vaccine against tick-borne encephalitis studied during the immunization of children and adolescents].
    Pavlova LI; Gorbunov MA; Vorob'eva MS; Karavanov AS; Grachev VP; Ladyshenskaia IP; Rasshchepkina MN; Mel'nikova LN; Lebedeva TM; Mel'nikov NA; Gusmanova AG; Deviatkov MIu; Rozanova EV; Mukachev MA
    Zh Mikrobiol Epidemiol Immunobiol; 1999; (6):50-3. PubMed ID: 10876850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serological response to tick-borne encephalitis (TBE) vaccination in the elderly--results from an observational study.
    Jílková E; Vejvalková P; Stiborová I; Skorkovský J; Král V
    Expert Opin Biol Ther; 2009 Jul; 9(7):797-803. PubMed ID: 19527104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed humoral immunity in a patient with severe tick-borne encephalitis after complete active vaccination.
    Kleiter I; Jilg W; Bogdahn U; Steinbrecher A
    Infection; 2007 Feb; 35(1):26-9. PubMed ID: 17297586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humoral immunity against tick-borne encephalitis virus following manifest disease and active immunization.
    Klockmann U; Bock HL; Kwasny H; Praus M; Cihlová V; Tomková E; Krivanec K
    Vaccine; 1991 Jan; 9(1):42-6. PubMed ID: 2008800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase 3 immunogenicity and safety study of a tick-borne encephalitis vaccine in healthy Japanese participants 1 year of age and older.
    Yonekawa M; Watanabe T; Kogawara O; Yoshii C; Yamaji M; Aizawa M; Erber W; Ito S; Jug B; Koelch D; de Solom R; Lockhart SP
    Vaccine; 2024 May; 42(13):3180-3189. PubMed ID: 38614954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.